日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Expression of ALDH1 isotypes and its potential as a prognostic and diagnostic marker in patients with muscle invasive bladder cancer.

ALDH1 同工型的表达及其作为肌层浸润性膀胱癌患者预后和诊断标志物的潜力

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-82460-1
Dey Sumit, Pattanaik Smita, Kakkar Nandita, Konar Monidipa, Panda Ipsita, Mandal Arup Kumar, Mavuduru Ravimohan Suryanarayan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Clinical study of steroid receptors in nonmuscle invasive bladder cancer: A domain worth revisiting

非肌层浸润性膀胱癌中类固醇受体的临床研究：一个值得重新审视的领域

期刊:Indian Journal of Urology
影响因子:0.9
doi:10.4103/iju.iju_324_23
Sharma, Aditya Prakash; Singh, Puranjay Pratap; Chauhan, Rohit; Panda, Ipsita; Devana, Sudheer Kumar; Bora, Girdhar S; Mavuduru, Ravimohan Suryanarayan; Kakkar, Nandita; Kumar, Santosh; Mete, Uttam
信号转导
肿瘤
肿瘤免疫
膀胱癌
发表日期：2024
文献求助 收藏

Case of chyluria mimicking nephrotic syndrome

一例乳糜尿酷似肾病综合征的病例

期刊:BMJ Case Reports
影响因子:0.5
doi:10.1136/bcr-2023-259042
Behera, Sanja Sameer; Sethi, Jasmine; Kumar, Rajesh; Mavuduru, Ravimohan Suryanarayan
发表日期：2024
文献求助 收藏

(177)Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial

(177)Lu-PSMA-617 与多西他赛治疗未经化疗的转移性去势抵抗性前列腺癌：一项随机、对照、II期非劣效性试验

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-021-05618-3
Satapathy, Swayamjeet; Mittal, Bhagwant Rai; Sood, Ashwani; Das, Chandan Krushna; Mavuduru, Ravimohan Suryanarayan; Goyal, Shikha; Shukla, Jaya; Singh, Shrawan Kumar
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Robot-assisted partial nephrectomy for moderate to highly complex renal masses. A systematic review and meta-analysis

机器人辅助部分肾切除术治疗中度至高度复杂肾脏肿块：系统评价和荟萃分析

期刊:Indian Journal of Urology
影响因子:0.9
doi:10.4103/iju.iju_393_21
Sharma, Gopal; Sharma, Aditya Prakash; Tyagi, Shantanu; Bora, Girdhar Singh; Mavuduru, Ravimohan Suryanarayan; Devana, Sudheer Kumar; Singh, Shrawan Kumar
发表日期：2022
文献求助 收藏

Robot-assisted surgery in India: A SWOT analysis

印度机器人辅助手术：SWOT分析

期刊:Indian Journal of Urology
影响因子:0.9
doi:10.4103/iju.IJU_220_19
Bora, Girdhar Singh; Narain, Tushar Aditya; Sharma, Aditya Prakash; Mavuduru, Ravimohan Suryanarayan; Devana, Sudheer K; Singh, Shrawan K; Mandal, Arup Kumar
发表日期：2020
文献求助 收藏

Robot-Assisted Nephron-Sparing Surgery of Renal Hydatid in Pregnancy: A Predicament in Management

妊娠期肾包虫病机器人辅助肾单位保留手术：治疗难题

期刊:Journal of Endourology Case Reports
影响因子:
doi:10.1089/cren.2020.0124
Bhirud, Deepak Prakash; Kumar, Sunil; Ranjan, Satish Kumar; Mavuduru, Ravimohan Suryanarayan; Mittal, Ankur
发表日期：2020
文献求助 收藏

Efficacy of tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms: A randomized double blind placebo controlled cross-over study

坦索罗辛和他达拉非缓解良性前列腺增生相关症状的疗效：一项随机双盲安慰剂对照交叉研究

期刊:Indian Journal of Urology
影响因子:0.9
doi:10.4103/iju.IJU_147_18
Pattanaik, Smita; Sandhu, Harbhupinder Singh; Mavuduru, Ravimohan Suryanarayan; Singh, Shrawan Kumar; Mandal, Arup Kumar
前列腺增生
免疫/内分泌
发表日期：2019
文献求助 收藏

Efficacy and safety of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy: A systematic review and meta-analysis

程序性死亡受体-1/程序性死亡配体-1抑制剂在晚期尿路上皮恶性肿瘤中的疗效和安全性：系统评价和荟萃分析

期刊:Indian Journal of Urology
影响因子:0.9
doi:10.4103/iju.IJU_357_18
Pattanaik, Smita; Dey, Sumit; Jaiswal, Nishant; Rohilla, Rachna; Singh, Shrawan Kumar; Mandal, Arup Kumar; Mavuduru, Ravimohan Suryanarayan
信号转导
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Protocol-based perioperative antimicrobial prophylaxis in urologic surgeries: Feasibility and lessons learned

基于方案的泌尿外科围手术期抗菌药物预防：可行性及经验教训

期刊:Indian Journal of Urology
影响因子:0.9
doi:10.4103/iju.IJU_270_18
Sharma, Aditya Prakash; Devana, Sudheer Kumar; Bora, Girdhar S; Mavuduru, Ravimohan Suryanarayan; Mohan, Balvinder; Taneja, Neelam; Singh, Shrawan K; Mandal, Arup K
发表日期：2019
文献求助 收藏